InteGen, founded in 2011 by Dr. Babu, is a biotechnology company specializing in the development of innovative and cost-effective FISH (Fluorescence In Situ Hybridization) probes for the cytogenetics community. The company focuses on providing tools for profiling chromosomes in the investigation of hematologic malignancies and products of conception. InteGen offers multi-color metaphase and interphase chromosome profiling, including a Rapid FISH technique with a 15-minute hybridization process.
Notable figures associated with InteGen include its founder, Dr. Babu, a board-certified clinical cytogeneticist. The company has made significant strides in the field of cytogenetics by developing clinically useful DNA FISH probes that enhance diagnostic capabilities while being cost-effective. InteGen's products have had a substantial impact on clinical practices, particularly in the areas of hematologic malignancies and reproductive health, contributing to more efficient and accurate genetic profiling.
